These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30829971)

  • 1. Use of PHQ-9 and pharmacogenetic testing in clinical practice.
    Kierce ED; Vanderhoef DM; Connors LM
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):497-501. PubMed ID: 30829971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing.
    Nooraeen S; Croarkin PE; Geske JR; Shekunov J; Orth SS; Romanowicz M; Frye MA; Vande Voort JL
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):28-33. PubMed ID: 38377526
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis.
    Round JM; Lee C; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    BMC Public Health; 2020 Jun; 20(1):987. PubMed ID: 32576158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
    Hall-Flavin DK; Winner JG; Allen JD; Carhart JM; Proctor B; Snyder KA; Drews MS; Eisterhold LL; Geske J; Mrazek DA
    Pharmacogenet Genomics; 2013 Oct; 23(10):535-48. PubMed ID: 24018772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study.
    Lloyd CE; Sartorius N; Ahmed HU; Alvarez A; Bahendeka S; Bobrov AE; Burti L; Chaturvedi SK; Gaebel W; de Girolamo G; Gondek TM; Guinzbourg M; Heinze MG; Khan A; Kiejna A; Kokoszka A; Kamala T; Lalic NM; Lecic-Tosevski D; Mannucci E; Mankovsky B; Müssig K; Mutiso V; Ndetei D; Nouwen A; Rabbani G; Srikanta SS; Starostina EG; Shevchuk M; Taj R; Valentini U; van Dam K; Vukovic O; Wölwer W
    Epidemiol Psychiatr Sci; 2020 Jun; 29():e134. PubMed ID: 32484148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting relapse in major depression after successful initial pharmacological treatment.
    Akechi T; Mantani A; Kurata K; Hirota S; Shimodera S; Yamada M; Inagaki M; Watanabe N; Kato T; Furukawa TA;
    J Affect Disord; 2019 May; 250():108-113. PubMed ID: 30851699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the Beck Depression Inventory-II (BDI-II) and Patient Health Questionnaire (PHQ-9) Depression Measures in an Outpatient Bariatric Clinic.
    Schutt PE; Kung S; Clark MM; Koball AM; Grothe KB
    Obes Surg; 2016 Jun; 26(6):1274-8. PubMed ID: 26341087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.
    Forester BP; Parikh SV; Weisenbach S; Ajilore O; Vahia I; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Conway CR; Shelton RC; Macaluso M; Li J; Traxler P; Logan J; Brown L; Dechairo B; Greden JF
    Am J Geriatr Psychiatry; 2020 Sep; 28(9):933-945. PubMed ID: 32513518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, management, and depression outcomes of primary care patients who endorse thoughts of death or suicide on the PHQ-9.
    Bauer AM; Chan YF; Huang H; Vannoy S; Unützer J
    J Gen Intern Med; 2013 Mar; 28(3):363-9. PubMed ID: 22936288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital.
    Sun Y; Fu Z; Bo Q; Mao Z; Ma X; Wang C
    BMC Psychiatry; 2020 Sep; 20(1):474. PubMed ID: 32993604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limited effect of screening for depressive symptoms with the PHQ-9 in rural family practices.
    Bergus GR; Hartz AJ; Noyes R; Ward MM; James PA; Vaughn T; Kelley PL; Sinift SD; Bentler S; Tilman E
    J Rural Health; 2005; 21(4):303-9. PubMed ID: 16294652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
    Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
    Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice?
    Zimmerman M; Walsh E; Friedman M; Boerescu DA; Attiullah N
    J Affect Disord; 2018 Jan; 225():449-452. PubMed ID: 28858659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled Trial.
    Olson MC; Maciel A; Gariepy JF; Cullors A; Saldivar JS; Taylor D; Centeno J; Garces JA; Vaishnavi S
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28314093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severity.
    Katzelnick DJ; Duffy FF; Chung H; Regier DA; Rae DS; Trivedi MH
    Psychiatr Serv; 2011 Aug; 62(8):929-35. PubMed ID: 21807833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Depression Management in an Integrated Psychiatric-Diabetes Education Clinic for Comorbid Depression and Diabetes Mellitus Types 1 and 2.
    Wong J; Mehta G
    Can J Diabetes; 2020 Aug; 44(6):455-460. PubMed ID: 32653155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PHQ-8 as a measure of current depression in the general population.
    Kroenke K; Strine TW; Spitzer RL; Williams JB; Berry JT; Mokdad AH
    J Affect Disord; 2009 Apr; 114(1-3):163-73. PubMed ID: 18752852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Patient Health Questionnaire depression screener in spinal cord injury.
    Poritz JMP; Mignogna J; Christie AJ; Holmes SA; Ames H
    J Spinal Cord Med; 2018 Mar; 41(2):238-244. PubMed ID: 28355958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating screening tools for depression in stroke and transient ischemic attack patients.
    Prisnie JC; Fiest KM; Coutts SB; Patten SB; Atta CA; Blaikie L; Bulloch AG; Demchuk A; Hill MD; Smith EE; Jetté N
    Int J Psychiatry Med; 2016 Apr; 51(3):262-77. PubMed ID: 27284119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.